{"data":[{"accessionNo":"0001346824-26-000239","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0002036042","issuerName":"SIONNA THERAPEUTICS, INC.","ticker":"SION","cusip":"829401108","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-09-17","reportingPerson":"Rajeev Shah","reportingCik":"0001619841","personType":"HC,IN","sharesOwned":6476193,"percentOfClass":14.3,"filedAt":"2026-09-21","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001346824-26-000239","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0002036042","issuerName":"SIONNA THERAPEUTICS, INC.","ticker":"SION","cusip":"829401108","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-09-17","reportingPerson":"Peter Kolchinsky","reportingCik":"0001384859","personType":"HC,IN","sharesOwned":6476193,"percentOfClass":14.3,"filedAt":"2026-09-21","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001346824-26-000239","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0002036042","issuerName":"SIONNA THERAPEUTICS, INC.","ticker":"SION","cusip":"829401108","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-09-17","reportingPerson":"RA Capital Management, L.P.","reportingCik":"0001346824","personType":"IA,PN","sharesOwned":6476193,"percentOfClass":14.3,"filedAt":"2026-09-21","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001346824-26-000239","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0002036042","issuerName":"SIONNA THERAPEUTICS, INC.","ticker":"SION","cusip":"829401108","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-09-17","reportingPerson":"RA Capital Healthcare Fund, L.P.","reportingCik":"0001315082","personType":"PN","sharesOwned":3448812,"percentOfClass":7.6,"filedAt":"2026-09-21","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001346824-26-000239","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0002036042","issuerName":"SIONNA THERAPEUTICS, INC.","ticker":"SION","cusip":"829401108","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-09-17","reportingPerson":"RA Capital Nexus Fund III, L.P.","reportingCik":"0001883840","personType":"PN","sharesOwned":2198082,"percentOfClass":4.9,"filedAt":"2026-09-21","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0000905148-26-002431","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","cusip":"829401108","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"VIKING GLOBAL INVESTORS LP","reportingCik":null,"personType":"PN","sharesOwned":3195181,"percentOfClass":7.1,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0000905148-26-002431","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","cusip":"829401108","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"Shabet Rose Sharon","reportingCik":null,"personType":"IN","sharesOwned":3195181,"percentOfClass":7.1,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0000905148-26-002431","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","cusip":"829401108","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"HALVORSEN OLE ANDREAS","reportingCik":null,"personType":"IN","sharesOwned":3195181,"percentOfClass":7.1,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0000905148-26-002431","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","cusip":"829401108","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"Viking Global Opportunities Parent GP LLC","reportingCik":null,"personType":"OO","sharesOwned":3195181,"percentOfClass":7.1,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0000905148-26-002431","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","cusip":"829401108","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"Viking Global Opportunities Illiquid Investments Sub-Master LP","reportingCik":null,"personType":"PN","sharesOwned":2039801,"percentOfClass":4.5,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0000905148-26-002431","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","cusip":"829401108","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"Viking Global Opportunities Portfolio GP LLC","reportingCik":null,"personType":"OO","sharesOwned":2039801,"percentOfClass":4.5,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0000905148-26-002431","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","cusip":"829401108","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"Viking Global Opportunities GP LLC","reportingCik":null,"personType":"OO","sharesOwned":2039801,"percentOfClass":4.5,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0000905148-26-002431","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","cusip":"829401108","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"Viking Global Opportunities Drawdown GP LLC","reportingCik":null,"personType":"OO","sharesOwned":1155380,"percentOfClass":2.6,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0000905148-26-002431","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","cusip":"829401108","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"Viking Global Opportunities Drawdown (Aggregator) LP","reportingCik":null,"personType":"PN","sharesOwned":1155380,"percentOfClass":2.6,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0000905148-26-002431","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","cusip":"829401108","securityClass":"Common Stock, $0.001 par value per share","eventDate":"2026-03-31","reportingPerson":"Viking Global Opportunities Drawdown Portfolio GP LLC","reportingCik":null,"personType":"OO","sharesOwned":1155380,"percentOfClass":2.6,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001441449-26-000005","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0002036042","issuerName":"Sionna Therapeutics Inc","ticker":"SION","cusip":"829401108","securityClass":"Common Stock SH","eventDate":"2026-03-31","reportingPerson":"Q Healthcare Holding LLC","reportingCik":null,"personType":"IV","sharesOwned":2020258,"percentOfClass":4.5,"filedAt":"2026-05-12","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001441449-26-000005","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0002036042","issuerName":"Sionna Therapeutics Inc","ticker":"SION","cusip":"829401108","securityClass":"Common Stock SH","eventDate":"2026-03-31","reportingPerson":"Qatar Investment Authority","reportingCik":null,"personType":"OO","sharesOwned":2020258,"percentOfClass":4.5,"filedAt":"2026-05-12","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0000947871-26-000456","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","cusip":"829401108","securityClass":"Common Stock","eventDate":"2026-04-15","reportingPerson":"OrbiMed Capital GP VIII LLC","reportingCik":"0001845804","personType":"OO","sharesOwned":2967722,"percentOfClass":6.6,"filedAt":"2026-04-20","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0000947871-26-000456","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0002036042","issuerName":"Sionna Therapeutics, Inc.","ticker":"SION","cusip":"829401108","securityClass":"Common Stock","eventDate":"2026-04-15","reportingPerson":"ORBIMED ADVISORS LLC","reportingCik":"0001055951","personType":"IA","sharesOwned":2967722,"percentOfClass":6.6,"filedAt":"2026-04-20","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001346824-25-000045","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0002036042","issuerName":"SIONNA THERAPEUTICS, INC.","ticker":"SION","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-11-05","reportingPerson":"RA Capital Management, L.P.","reportingCik":"0001346824","personType":"IA,PN","sharesOwned":10071712,"percentOfClass":22.6,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001346824-25-000045","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0002036042","issuerName":"SIONNA THERAPEUTICS, INC.","ticker":"SION","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-11-05","reportingPerson":"Peter Kolchinsky","reportingCik":"0001384859","personType":"HC,IN","sharesOwned":10071712,"percentOfClass":22.6,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001346824-25-000045","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0002036042","issuerName":"SIONNA THERAPEUTICS, INC.","ticker":"SION","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-11-05","reportingPerson":"Rajeev Shah","reportingCik":"0001619841","personType":"HC,IN","sharesOwned":10071712,"percentOfClass":22.6,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001346824-25-000045","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0002036042","issuerName":"SIONNA THERAPEUTICS, INC.","ticker":"SION","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-11-05","reportingPerson":"RA Capital Healthcare Fund, L.P.","reportingCik":"0001315082","personType":"PN","sharesOwned":6905625,"percentOfClass":15.5,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001346824-25-000045","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0002036042","issuerName":"SIONNA THERAPEUTICS, INC.","ticker":"SION","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-11-05","reportingPerson":"RA Capital Nexus Fund III, L.P.","reportingCik":"0001883840","personType":"PN","sharesOwned":2240708,"percentOfClass":5,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001708269-25-000004","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0002036042","issuerName":"SIONNA THERAPEUTICS, INC.","ticker":"SION","cusip":null,"securityClass":"Common Stock","eventDate":"2025-10-16","reportingPerson":"Atlas Venture Fund XI, L.P.","reportingCik":"0001708269","personType":"PN","sharesOwned":2382495,"percentOfClass":5.4,"filedAt":"2025-10-20","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001708269-25-000004","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0002036042","issuerName":"SIONNA THERAPEUTICS, INC.","ticker":"SION","cusip":null,"securityClass":"Common Stock","eventDate":"2025-10-16","reportingPerson":"Atlas Venture Associates XI, L.P.","reportingCik":"0001780068","personType":"PN","sharesOwned":2382495,"percentOfClass":5.4,"filedAt":"2025-10-20","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001708269-25-000004","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0002036042","issuerName":"SIONNA THERAPEUTICS, INC.","ticker":"SION","cusip":null,"securityClass":"Common Stock","eventDate":"2025-10-16","reportingPerson":"Atlas Venture Associates XI, LLC","reportingCik":"0001780067","personType":"OO","sharesOwned":2382495,"percentOfClass":5.4,"filedAt":"2025-10-20","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001708269-25-000004","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0002036042","issuerName":"SIONNA THERAPEUTICS, INC.","ticker":"SION","cusip":null,"securityClass":"Common Stock","eventDate":"2025-10-16","reportingPerson":"Atlas Venture Opportunity Fund II, L.P.","reportingCik":"0001885327","personType":"PN","sharesOwned":701985,"percentOfClass":1.6,"filedAt":"2025-10-20","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001708269-25-000004","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0002036042","issuerName":"SIONNA THERAPEUTICS, INC.","ticker":"SION","cusip":null,"securityClass":"Common Stock","eventDate":"2025-10-16","reportingPerson":"Atlas Venture Associates Opportunity II, LP","reportingCik":"0001935814","personType":"PN","sharesOwned":701985,"percentOfClass":1.6,"filedAt":"2025-10-20","canonicalUrl":"https://xoomar.com/markets/stocks/sion"},{"accessionNo":"0001708269-25-000004","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0002036042","issuerName":"SIONNA THERAPEUTICS, INC.","ticker":"SION","cusip":null,"securityClass":"Common Stock","eventDate":"2025-10-16","reportingPerson":"Atlas Venture Associates Opportunity II, LLC","reportingCik":"0001935810","personType":"OO","sharesOwned":701985,"percentOfClass":1.6,"filedAt":"2025-10-20","canonicalUrl":"https://xoomar.com/markets/stocks/sion"}],"updatedAt":"2026-11-05T10:17:21.635Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/sion","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}